Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 5 results.
User Information
Export Records
  1. 1.   IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
  2. Harper, Taylor A.; Bacot, Silvia M.; Fennell, Christie Jane; Matthews,Rebecca; Zhu, Christina; Yue, Peng; Benton, Alexander; Friedman, Devira; Akue, Adovi; KuKuruga, Mark A.; Lee, Shiowjen; Wang, Tao; Feldman, Gerald M.
  3. International Journal of Molecular Sciences. 2021, Nov; 22(21):
  1. 2.   Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies
  2. Gross, Andrea M; Frone, Megan; Gripp, Karen W; Gelb, Bruce D; Schoyer, Lisa; Schill, Lisa; Stronach, Beth; Biesecker, Leslie G; Esposito,Dom; Hernandez, Edjay Ralph; Legius, Eric; Loh, Mignon L; Martin, Staci; Morrison,Deborah; Rauen, Katherine A; Wolters, Pamela L; Zand, Dina; McCormick, Frank; Savage, Sharon A; Stewart, Douglas R; Widemann, Brigitte C; Yohe, Marielle E
  3. American journal of medical genetics. Part A. 2020, APR; 182(4): 866-876.
  1. 3.   Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells
  2. Hodge, D. R.; Xiao, W. H.; Wang, L. H.; Li, D. P.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2004 3(2): 188-194.
  1. 4.   Protein phosphatase 2A positively regulates ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites
  2. Ory, S.; Zhou, M.; Conrads, T. P.; Veenstra, T. D.; Morrison, D. K.
  3. Current Biology. 2003 13(16): 1356-1364.
  1. 5.   AP-1, NF kappa B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model
  2. Suzukawa, K.; Weber, T. J.; Colburn, N. H.
  3. Environmental Health Perspectives. 2002 110(9): 865-870.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel